MedTrace Logo

An Evaluation of the Safety and Efficacy of FID 114657

NCT01030237 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 153

Last updated 2012-02-02

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of FID 114657 in comparison to Soothe XP in a specified population of dry eye patients.

Conditions

  • Dry Eye

Interventions

OTHER

FID 114657

1 drop both eyes four times a day for 6 weeks

OTHER

Soothe XP Lubricant Eye Drops

1 drop both eyes four times a day for 6 weeks

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01030237 on ClinicalTrials.gov